ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Condition:   Alopecia Intervention:   Drug: ATI-501 Sponsor:   Aclaris Therapeutics, Inc. Recruiting

Source: ClinicalTrials.gov - July 20, 2018 Category: Research Source Type: clinical trials